Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

GeneDx Holdings (WGS) Other Non Operating Income: 2020-2025

Historic Other Non Operating Income for GeneDx Holdings (WGS) over the last 5 years, with Sep 2025 value amounting to -$174,000.

  • GeneDx Holdings' Other Non Operating Income fell 115.21% to -$174,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$440,000, marking a year-over-year increase of 96.44%. This contributed to the annual value of -$13.0 million for FY2024, which is 903.83% down from last year.
  • According to the latest figures from Q3 2025, GeneDx Holdings' Other Non Operating Income is -$174,000, which was down 172.80% from $239,000 recorded in Q2 2025.
  • GeneDx Holdings' Other Non Operating Income's 5-year high stood at $5.6 million during Q1 2021, with a 5-year trough of -$13.5 million in Q2 2024.
  • Its 3-year average for Other Non Operating Income is -$1.0 million, with a median of $37,000 in 2024.
  • In the last 5 years, GeneDx Holdings' Other Non Operating Income plummeted by 56,800.00% in 2023 and then soared by 464.86% in 2025.
  • GeneDx Holdings' Other Non Operating Income (Quarterly) stood at $50,000 in 2021, then slumped by 102.00% to -$1,000 in 2022, then crashed by 4,800.00% to -$49,000 in 2023, then crashed by 1,357.14% to -$714,000 in 2024, then slumped by 115.21% to -$174,000 in 2025.
  • Its Other Non Operating Income was -$174,000 in Q3 2025, compared to $239,000 in Q2 2025 and $209,000 in Q1 2025.